Effect of different resuscitation fluids on cytokine response in a rat model of hemorrhagic shock

Shock

Volumn 24, Issue 2, 2005, Pages 177-181

  Lee, Chien Chang ^a   Chang, I Jing ^b   Yen, Zui Shen ^a   Hsu, Chiung Yuan ^a   Chen, Shey Yiny ^a   Su, Chan Ping ^a   Chiang, Wen Chu ^a   Chen, Shyr Chyr ^a   Chen, Wen Jone ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Anaphylactoid reaction; Cytokine; Gelatin; Hemorrhagic shock; Hydroxyethyl starch; Lactated Ringer; Resuscitation fluids

Indexed keywords

GELATIN; HETASTARCH; INTERLEUKIN 10; INTERLEUKIN 6; RINGER LACTATE SOLUTION; TUMOR NECROSIS FACTOR ALPHA;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL MODEL; FLUID THERAPY; HEMORRHAGIC SHOCK; IMMUNE RESPONSE; INFLAMMATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOPHYSIOLOGY; RAT; RESUSCITATION; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

ANIMALS; BLOOD PRESSURE; CYTOKINES; DISEASE MODELS, ANIMAL; FLUID THERAPY; HEMATOCRIT; HEMORRHAGE; HETASTARCH; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; ISOTONIC SOLUTIONS; LUNG; MALE; RATS; RATS, WISTAR; RESUSCITATION; SHOCK, HEMORRHAGIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 23344447890     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000171870.42900.15     Document Type: Article

References (33)

1. Committee on Trauma Research, National Research Council, and the Institute of Medicine.: Injury in America, A Continuing Public Health Problem. Washington, DC: National Academy Press; 1985:65-80.
2. Lee CC, Marill KA, Carter WA, Crupi RS: A current concept of trauma-induced multiorgan failure. Ann Emerg Med 38:170-176, 2001.
3. Napolitano LM, Faist E, Wichmann MW, Coimbra R: Immune dysfunction in trauma. Surg Clin North Am 79:1385-1416, 1999.
4. Waxman K: What mediates tissue injury after shock. New Horiz 4:151-153, 1996.
5. Waxman K: Shock: ischemia reperfusion, and inflammation. New Horiz 4:153-160, 1996.
6. Faist E, Wichmann M, Baue AE: The immune response. In Mattox KL, Feliciano DV. Moore EE (eds.): Trauma. New York: McGraw-Hill. 2000, pp 1409-1424.
7. Boldt J, Muller M, Heesen M, Neumann K, Hempelmann GG: Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med 24:385-391, 1996.
8. Rhee P, Wang D, Ruff P, Austin B, DeBraux S, Wolcott K, Burris D, Ling G, Sun L: Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 28:74-78, 2000.
9. Rhee P, Burris D, Kaufmann C, Pikoulis M, Austin B, Ling G, Harviel D, Waxman K: Lactated Ringer's solution resuscitation causes neutrophil activation after hemorrhagic shock. J Trauma 44:313-319, 1998.
10. Moore FA, Moore E, Sauaia A: Blood transfusion: an independent risk factor for postinjury multiple organ failure. Arch Surg 132:620-624, 1997.
11. Hensler T, Heinemann B, Sauerland S, Lefering R, Bouillon B, Andermahr J, Neugebauer EA: Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock 20:497-502, 2003.
12. Alderson P, Schierhout G, Roberts I, Bunn F: Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2: CD000567, 2000.
13. Rizoli SB: Crystalloids and colloids in trauma resuscitation: a brief overview of the current debate. J Trauma 54:S82-S88, 2003.
14. Engel JM, Welters I, Rupp M, Langefeld T, Ruwoldt R, Menges T, Hempelmann G: Influence of colloid fluids on polymorphonuclear granulocyte function in vivo. Acta Anaesthesiol Scand 45:385-389, 2001
15. Jaeger K, Heine J, Ruschulte H, Juttner B, Scheinichen D, Kuse ER, Piepenbrock S: Effects of colloidal resuscitation fluids on the neutrophil respiratory burst. Transfusion 41:1064-1068, 2001.
16. Boldt J, Heesen M, Muller M, Hempelmann G: The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 83:254-261, 1996.
17. Allison KP, Gosling P, Jones S, Pallister I, Porter KM: Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. J Trauma 47:1114-1121, 1999.
18. Barron ME, Wilkes MM, Navickis RJ: A systematic review of the comparative safety of colloids. Arch Surg 139:552-563, 2004.
19. Bunn F, Alderson P, Hawkins V: Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 1:CD001319, 2003.
20. Dinarello CA: Cytokines as mediators in the pathogenesis of septic shock. Curr Top Microbiol Immunol 216:133-165, 1996.
21. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK: IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101:311-320, 1998.
22. Beutler B, Grau GE: Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 21:S423-S435, 1993.
23. Schneider CP, Schwacha MG, Chaudry IH: The role of interleukin-10 in the regulation of the systemic inflammatory response following traumahemorrhage. Biochim Biophys Acta 1689:22-32, 2004.
24. Saddler JM, Horsey PJ: The new generation gelatins. A review of their history, manufacture and properties. Anaexthesia 42:998-1004, 1987.
25. Trieb J, Baron JF, Grauer MT: An international view of hyrdoxylethyl starches. Intensive Care Med 25:258-268, 1999.
26. Rittoo D, Gosling P, Burnley S, Bonnici C, Millns P, Simms MH, Smith SR, Vohra RK: Randomized study comparing the effects of hydroxyethyl starch solution with Gelofusine on pulmonary function in patients undergoing abdominal aortic aneurysm surgery. Br J Anaesth 92:61-66, 2004.
27. Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT: Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 40:613-616, 1996.
28. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A: The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma. Am J Emerg Med 17:548-551, 1999.
29. Treib J, Haass A, Pindur G: Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 78:974-983, 1997.
30. Sainte-Laudy J, Cado S: Comparison of the levels of histamine, tryptase, and interleukin-6 for the investigation of anaphylactoid drug reactions. Allergy Immunol 30:209-211, 1998.
31. Lin RY, Trivino MR, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L, Tenenbaum C, Westfal RE: Interleukin 6 and C-reactive protein levels in patients with acute allergic reactions: an emergency department-based study. Ann Allergy Asthma Immunol 87:412-416, 2001.
32. Ring J, Messmer K: Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1:466-469, 1977.
33. Laxenaire MC, Charpentier C, Feldman L: Anaphylactoid reactions to colloid plasma substitutes: incidence risk factors mechanisms. Ann Fr Anesth Reanim 13:301-310, 1994.